In AD, the long-term activation of toll-like receptor 4 (TLR-4), by damage-associated molecular patterns (DAMPs), such as lipopolysaccharide (LPS) or Aβ, can activate the glial cell to polarize to an M1 phenotype, increasing a chronic inflammatory response [25,26,27]. The gene discussed is TLR4; the disease is Alzheimer disease.